Medical Devices

With an 11% dividend hike and 22 years of growth, ADI proves its stability while investing heavily in the future of AI, automotive, and healthcare.

Cindy Eckert's TIME100 nod follows a major FDA win for her libido drug, Addyi, but spotlights a decade-long battle over efficacy, safety, and equality.

With over 2 million visitors at Expo 2025, Thailand showcased breakthrough medical tech. But can it translate this success into a global healthcare powerhouse?

Genmab posts record 2025 revenue, driven by cancer drug sales and a major acquisition, setting an ambitious, investment-heavy course for 2026.

Primex Inc. hires a life sciences expert to drive its OneVue Sense solution deeper into the critical and highly regulated healthcare and biopharma markets.

A new study shows an AI-powered device can identify infants at high risk for atopic dermatitis at birth, paving the way for proactive, preventative care.

Integrity College of Health's maximum six-year reaccreditation offers a key validation for parent company Legacy Education amid a shifting regulatory climate.

The largest study of its kind reveals metabolic signatures that predict severe neurotoxicity in CAR T-cell patients, paving the way for safer treatments.

A key Medtrade 2026 panel led by Synapse Health will unite industry leaders to chart the future of value-based care in the DME market.

With a new CTO and fortified legal and quality chiefs, Integra LifeSciences is making a bold play to accelerate innovation and shore up compliance.

Two Pasco County communities are among the nation's top sellers. Their secret? A 15-acre lagoon, a residential farm, and a new vision for community life.

A major update to the Kosmos platform brings cart-grade OB/GYN and vascular tools to a portable device, reshaping diagnostics from the ER to rural clinics.

In a landmark $9.9 billion all-cash deal, Danaher will acquire Masimo, aiming to dominate the patient monitoring market from hospital to home.

With a new rotator cuff device and enhanced meniscal repair system, Arcuro Medical is challenging orthopedic giants with its innovative all-suture technology.

Annexon Biosciences spotlights its novel C1q inhibitor, Vonaprument, aiming to be the first therapy to preserve vision in geographic atrophy patients.

In a strategic move to restore trust in digital health, HealthCentral has acquired an AI platform that vets and activates physician influencers.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

Israeli tech firm Nanox will debut its low-cost Nanox.ARC imaging system in Europe, pairing it with AI that spots chronic disease in routine scans.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.